ROBERT WUN LIMITED
Company number 08825410 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: ROBERT WUN LIMITED
1. Financial Health Score: D+
Explanation: The company is technically insolvent on paper, meaning its total liabilities exceed its total assets. This is the financial equivalent of a patient with a chronic heart condition—it requires continuous life support to survive. However, the score is elevated to a D+ because the business is showing encouraging signs of operational recovery. It returned to profitability in the latest year, and the director has provided a formal, long-term "life support" undertaking until 2035, mitigating the immediate risk of collapse.
2. Key Vital Signs
- Net Assets (Equity): -£105,392 Interpretation: This is a chronic condition. The company’s liabilities exceed its assets, resulting in negative shareholder funds. However, this is an improvement from the prior year (-£128,577), indicating that the patient is slowly recovering from a much worse state (-£429,261 in 2021).
- Pulse (Profitability): £23,185 Profit Interpretation: The patient's heart is beating again. After years of apparent losses, the company generated a profit in 2025. This is the most vital sign of organic business health improvement.
- Blood Pressure (Liquidity): 0.76 Current Ratio Interpretation: Dangerously high blood pressure. Current liabilities (£433,697) significantly outweigh current assets (£330,974). Without external support, the company cannot cover its short-term debts if they were all called in at once.
- Oxygen Supply (Cash Reserves): £49,907 Interpretation: Cash levels have dropped significantly from £247,318 in 2024. The business is burning through its cash reserves, likely because cash is tied up in unpaid invoices rather than in the bank.
- Arterial Blockage (Debtors): £281,067 Interpretation: There is a massive blockage. Trade and other debtors have skyrocketed from £61,260 to £281,067. The business is making sales, but the cash isn't flowing through—it's stuck in the arteries.
3. Diagnosis
Diagnosis: Chronic Balance Sheet Insolvency with Acute Cash Flow Blockage, supported by Director Life Support
The financial data reveals a business that has successfully revitalized its top-line operations—doubling its workforce from 3 to 6 employees and generating a £23,185 profit—but is suffering from severe balance sheet weakness. The company is balance sheet insolvent (negative net assets), which typically signals a terminal condition.
However, the company is surviving on a financial ventilator: Director Robert Wun has absorbed £403,367 of connected person debt into a personal, interest-free loan payable on demand (£398,999 is now owed to him). He has also provided a legally binding undertaking to continue funding the business until December 31, 2035. This life support mechanism prevents insolvency proceedings, but it does not cure the underlying lack of organic capital.
The most pressing symptom is the severe cash flow blockage. While the business generated sales, cash dropped by nearly £200k. This is almost entirely attributable to the £219k increase in debtors. The business is selling its services, but clients are not paying fast enough, forcing the company to rely on the director's reserves to stay afloat.
4. Recommendations
To improve financial wellness and eventually wean the business off director life support, the following treatments are prescribed:
- Clear the Arterial Blockage (Improve Debt Collection): The most urgent priority is converting the £281,067 in debtors into cash. Implement stricter credit control procedures, shorten payment terms for clients, and consider offering early payment discounts. The business cannot afford to act as a bank for its clients.
- Monitor Cash Burn Rate: With cash dropping from £247k to £49k despite making a profit, the business must rigorously track its cash flow forecasting. Ensure that operational expenses are tightly managed and aligned with actual cash receipts, not just paper profits.
- Formalize Director Loan Repayment Strategy: While the director's undertaking until 2035 provides stability, the company should aim to build enough organic retained earnings to clear the negative net assets. Once the debtors are collected and cash flow stabilizes, establish a structured, affordable schedule to repay the director's loan from future profits rather than relying on it for day-to-day working capital.
- Review Creditor Pressure: Trade creditors have doubled from £12,208 to £25,444. As the business scales, ensure supplier terms are negotiated favorably to prevent short-term creditor pressure from exacerbating the liquidity issues.